455 filings
Page 16 of 23
4
John Woock
4 Dec 19
Axonics Modulation / John Woock ownership change
8:13pm
SC 13D/A
AXNX
Axonics Inc
3 Dec 19
Axonics Modulation Technologies, Inc.
4:30pm
SC 13D/A
Cooperatieve Gilde Healthcare IV U.A.
27 Nov 19
Axonics Modulation Technologies, Inc.
2:45pm
4
Andera Partners
26 Nov 19
Axonics Modulation / 4 FCPR BioDiscovery ownership change
9:07pm
4
Danny L. Dearen
25 Nov 19
Axonics Modulation / Danny L. Dearen ownership change
4:08pm
8-K
AXNX
Axonics Inc
22 Nov 19
Axonics® Announces Closing of $110 Million
4:45pm
4
AXNX
Axonics Inc
22 Nov 19
Axonics Modulation / Raphael Wisniewski ownership change
7:29am
4
Danny L. Dearen
21 Nov 19
Axonics Modulation / Danny L. Dearen ownership change
8:42pm
4
AXNX
Axonics Inc
21 Nov 19
Axonics Modulation / RAYMOND W COHEN ownership change
8:42pm
424B5
AXNX
Axonics Inc
21 Nov 19
Prospectus supplement for primary offering
5:21pm
8-K
AXNX
Axonics Inc
20 Nov 19
Proposed Public Offering of Common Stock
4:59pm
424B5
AXNX
Axonics Inc
19 Nov 19
Prospectus supplement for primary offering
4:35pm
EFFECT
AXNX
Axonics Inc
19 Nov 19
Notice of effectiveness
12:15am
CORRESP
AXNX
Axonics Inc
15 Nov 19
Correspondence with SEC
12:00am
8-K
AXNX
Axonics Inc
14 Nov 19
Axonics® Announces U.S. Food & Drug Administration Approval for its Sacral Neuromodulation System for Urinary Clinical Indications
5:19pm
10-Q
2019 Q3
AXNX
Axonics Inc
Quarterly report
14 Nov 19
4:31pm
8-K
AXNX
Axonics Inc
14 Nov 19
Axonics® Announces Third Quarter 2019 Financial Results and Operational Update
4:05pm
UPLOAD
AXNX
Axonics Inc
14 Nov 19
Letter from SEC
12:00am
CORRESP
AXNX
Axonics Inc
14 Nov 19
Correspondence with SEC
12:00am
S-3
AXNX
Axonics Inc
6 Nov 19
Shelf registration
5:23pm